Actively Recruiting
Predictive Role of sTREM in Endovascular Thrombectomy Outcomes
Led by The Affiliated Hospital of Xuzhou Medical University · Updated on 2024-08-09
300
Participants Needed
1
Research Sites
182 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Soluble triggering receptor expressed on myeloid cells (sTREM), which reflects microglia activation, has been reported closely associated with neuronal injury and neuroinflammation. This study is to investigatethe prognostic roles of sTREM (sTREM1 and sTREM2) in patients with ischemic stroke who underwent endovascular thrombectomy (EVT).
CONDITIONS
Official Title
Predictive Role of sTREM in Endovascular Thrombectomy Outcomes
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients > 18 years old.
- Patients with acute large vessel occlusion within 24 hours of onset who will receive endovascular treatment.
You will not qualify if you...
- Impossibility of getting a blood sample.
- Impossibility of performing the test (Invalid results).
- Refusal to provide the informed consent by the patient/relative.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Department of Neurology
Xuzhou, Jiangsu, China
Actively Recruiting
Research Team
X
Xingzhi Wang, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here